Efficient identification of miRNAs for classification of tumor origin

J Mol Diagn. 2014 Jan;16(1):106-15. doi: 10.1016/j.jmoldx.2013.10.001. Epub 2013 Nov 5.

Abstract

Carcinomas of unknown primary origin constitute 3% to 5% of all newly diagnosed metastatic cancers, with the primary source difficult to classify with current histological methods. Effective cancer treatment depends on early and accurate identification of the tumor; patients with metastases of unknown origin have poor prognosis and short survival. Because miRNA expression is highly tissue specific, the miRNA profile of a metastasis may be used to identify its origin. We therefore evaluated the potential of miRNA profiling to identify the primary tumor of known metastases. Two hundred eight formalin-fixed, paraffin-embedded samples, representing 15 different histologies, were profiled on a locked nucleic acid-enhanced microarray platform, which allows for highly sensitive and specific detection of miRNA. On the basis of these data, we developed and cross-validated a novel classification algorithm, least absolute shrinkage and selection operator, which had an overall accuracy of 85% (CI, 79%-89%). When the classifier was applied on an independent test set of 48 metastases, the primary site was correctly identified in 42 cases (88% accuracy; CI, 75%-94%). Our findings suggest that miRNA expression profiling on paraffin tissue can efficiently predict the primary origin of a tumor and may provide pathologists with a molecular diagnostic tool that can improve their capability to correctly identify the origin of hitherto unidentifiable metastatic tumors and, eventually, enable tailored therapy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Algorithms
  • Base Sequence
  • Biomarkers, Tumor / genetics
  • Gene Expression Profiling / methods
  • Gene Expression Regulation, Neoplastic
  • Humans
  • MicroRNAs / genetics*
  • Molecular Diagnostic Techniques / methods*
  • Neoplasms, Unknown Primary / classification*
  • Neoplasms, Unknown Primary / diagnosis
  • Neoplasms, Unknown Primary / genetics*
  • Oligonucleotide Array Sequence Analysis / methods
  • Organ Specificity / genetics
  • Paraffin Embedding
  • Sequence Analysis, RNA / methods*

Substances

  • Biomarkers, Tumor
  • MicroRNAs